Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03139851
Brief Title: Evaluation of Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated With Metronomic Cyclophosphamide (CHEMOIMMUNE)

First Submitted : April 10, 2017
First Submitted that Met QC Criteria : May 2, 2017
First Posted : May 4, 2017

Last Update Submitted that Met QC Criteria : August 26, 2020
Last Update Posted : August 27, 2020